Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Claire Stawnyczy, CEO of Lophos Pharmaceuticals Corp. was a guest speaker at Benzinga’s Psychedelics Capital Conference on April 19, 2022. 

Lophos Pharma is a pioneering biosciences company cultivating more sustainably harvested peyote-derivatives. It’s researching a range of physical and mental health applications for the plant that has a long history of use in traditional indigenous medicine.

Watch the full interview here.

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Image provided by Pixabay


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: PsychedelicsMarketsBenzinga Psychedelic Capital ConferenceLophos PharmaPartner Content